Dapagliflozin API powder

Xi'an Faithful BioTech Co., Ltd: Your Raw Dapagliflozin API powder Manufacturer & Supplier

Xi'an Faithful BioTech Co., Ltd focuses on the supply of high-end pharmaceutical raw materials. We have been deeply involved in the pharmaceutical and chemical industry for many years. The production base we cooperate with is in line with modern drug production bases, equipped with advanced synthesis and testing equipment. Our core product Dapagliflozin API powder strictly follows CP quality standards and has passed multiple quality system certifications. We adhere to the concept of "quality as the root, integrity-based, and innovation as the wing", focusing on the supply of raw materials for major diseases such as endocrine and cardiovascular diseases, and providing stable and reliable products for global pharmaceutical companies and research institutions.

Dapagliflozin API powder Introduction

Dapagliflozin API powder is a highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor. As a heavyweight pharmaceutical raw material, its original powder is a white to off white crystalline powder with a purity of not less than 99%. Its mechanism of action is unique, by inhibiting the reabsorption of glucose by the renal proximal tubules, promoting the daily excretion of about 80g of glucose through urine, thereby achieving hypoglycemic effects without relying on the function of blood glucose regulators. It is widely used clinically and has been approved for adult type 2 diabetes (single drug or combined treatment), heart failure with reduced ejection fraction, chronic kidney disease with risk of progression and other indications. Regardless of whether the patient is complicated with diabetes, it can significantly reduce the risk of cardiovascular death, hospitalization and deterioration of renal function. In addition, it also has additional benefits such as weight loss, blood pressure reduction, and uric acid reduction, making it a versatile raw material with multiple organ protection effects, and the market demand continues to grow steadily.

Specifications

 Why Choose Us?

Through multiple detection methods such as infrared spectroscopy and high-performance liquid chromatography, it has no pyrogen, strict aseptic control, strong batch stability, and a product purity of up to 99%;

Adequate annual production capacity, supporting multi specification packaging such as 25KG/cardboard drums, can meet bulk procurement and emergency replenishment needs, ensuring supply chain stability;

By optimizing the synthesis process and supply chain management, we ensure quality while controlling costs, providing customers with more competitive prices in the market and achieving win-win development;

Adopting multi-channel transportation to achieve high efficiency and safety.  

Main applications

• Core raw materials for pharmaceutical production: used to prepare Dapagliflozin tablets, capsules and other clinical preparations to meet the treatment needs of type 2 diabetes, heart failure, chronic kidney disease and other diseases.
• Drug development and improvement: providing high-purity raw materials for pharmaceutical companies, supporting the development of new dosage forms, consistency evaluation of generic drugs, and research on combination therapy.
• Research and clinical trials: for research institutions to conduct cutting-edge research on the mechanism of action and indications of SGLT2 inhibitors, such as metabolic related fatty liver disease and polycystic ovary syndrome.
• Quality standard reference material: can be used as a standard reference material for pharmaceutical testing institutions, for drug quality control and inspection calibration.

if you need it , you can click here

Quality Control:

R&D Results:

Packaging and Transportation:

After-Sales Service:

Qualification Certification:

Exhibition:

FAQ

Q1:What is the protein binding rate of Dapagliflozin?

A1:Dapagliflozin has a protein binding rate of 91% and a bioavailability of approximately 78%.

Q2:Does liver and kidney function affect the pharmacokinetics of dapagliflozin?

A2:Liver and kidney function have a significant impact on the pharmacokinetics of dapagliflozin, and renal dysfunction can greatly reduce urinary glucose excretion.

Q3:What are the common adverse reactions of Dapagliflozin?

A3: Common adverse reactions include hypoglycemia, polyuria, back pain, genital infections, urinary tract infections, dyslipidemia, and increased hematocrit.

Contact Us

Empowering pharmaceutical innovation with high-quality Dapagliflozin API powder and safeguarding the health industry with professional services, we look forward to becoming your reliable partner, Contact us sales1@faithfulbio.com if you have any questions.